Artificial Intelligence in Precision Oncology: A Revolution in Cancer Diagnosis and Treatment

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 216

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

AIMS02_554

تاریخ نمایه سازی: 29 تیر 1404

چکیده مقاله:

Background and Aims: The process of treatment selection in oncology medicine involves reviewing distinct patient information along with results from genomic and molecular laboratory examinations. Medical disease databases now require advanced computational approaches and artificial intelligence stands out as an effective technology to discover significant outcomes within these vast datasets. The development of precision oncology requires artificial intelligence because it enables efficient examination of intricate dataset information. This article examines current AI applications to identify and provide personalized treatment for cancer patients alongside their primary achievements and necessary study directions. Methods: The research included systematic database queries of PubMed and Scopus and Web of Science for peer-reviewed papers from ۲۰۱۸ to ۲۰۲۵. The search incorporated artificial intelligence, machine learning, deep learning, precision oncology, cancer detection, and cancer treatment among the keyword group. Studies from Q۱ journals served as the research criteria because they provided a standard of high-quality evidence. Results: Cancer detection experienced major progress because deep learning models excel at determining malignant cases through advanced image analysis of radiological images and pathological samples. AI convolutional neural networks derived from deep learning technology detect breast cancer and lung cancer effectively in mammograms and CT scans resulting in AUC values reaching ۰.۹۹ and higher levels of excellence. The combination of actionable mutations analysis in next-generation sequencing data helps predict treatment possibilities through machine learning integration with multi-omics data to create patient stratification models. AI-based tools speed up treatment development processes through their capability to find and repurpose drugs at a faster rate. Conclusion: Precision oncology shows strong potential after adding AI because research shows AI tools achieve excellent results at determining diagnoses and prognoses and selecting appropriate treatments. The ability of AI to decode challenging multi-omics data systems enables medical professionals to deliver individualized care to patients. Current AI applications face ongoing barriers

نویسندگان

Ali Honari Jahromi

Autophagy Research Center, Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Parisa Alipour

Division of Laboratory Hematology and Blood Banking, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

Raziyeh Jorjani

Biology Department, Faculty of Sciences, Gonbad Kavous University, Golestan, Iran

Kiana Khajeheian

Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran